Castro-Marrero, Jesús, Cordero, Mario D, Sáez-Francas, Naia et al. · Antioxidants & redox signaling · 2013 · DOI
This study looked at whether problems in the energy-producing parts of cells (mitochondria) might be different between ME/CFS and fibromyalgia, two conditions that cause fatigue and are often confused with each other. Researchers tested blood cells from people with ME/CFS, fibromyalgia, and healthy people, measuring energy-related markers and signs of cellular damage. They found that both conditions showed some mitochondrial problems, but the patterns were different—suggesting mitochondrial dysfunction might help doctors tell these two conditions apart.
Distinguishing ME/CFS from fibromyalgia is clinically challenging, and both conditions lack validated biomarkers. If mitochondrial markers can reliably differentiate these diseases, it could improve diagnosis and guide targeted treatments. This study adds to growing evidence that mitochondrial dysfunction may be central to ME/CFS pathophysiology.
This study does not prove that mitochondrial dysfunction causes ME/CFS or fibromyalgia—only that differences exist. Small sample sizes (especially the control group) limit generalizability, and single timepoint measurements cannot establish whether these markers are stable or change over disease course. The findings require replication in larger, independent cohorts before clinical application.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →